✦ LIBER ✦

Onset and Duration of Action of Ketotifen 0.025% and Emedastine 0.05% in Seasonal Allergic Conjunctivitis

✍ Scribed by Prof. Friedrich Horak, Petra Stübner, René Zieglmayer, Alexander Kawina, Michael Moser, René Lanz

Book ID: 119929834
Publisher: Springer International Publishing AG
Year: 2003
Tongue: English
Weight: 118 KB
Volume: 23
Category: Article
ISSN: 1179-1918
DOI: 10.2165/00044011-200323050-00003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of olopatadine HCI 0.1%, ketoti

Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial

✍ Mehmet Borazan; Aylin Karalezli; Yonca Aydin Akova; Ahmet Akman; Halil Kiyici; S 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 141 KB

Efficacy and safety of ketotifen fumarat

Efficacy and safety of ketotifen fumarate 0.025% in the conjunctival antigen challenge model of ocular allergic conjunctivitis

✍ Jack V Greiner; Thomas Mundorf; Harvey Dubiner; John Lonsdale; Richard Casey; Le 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 193 KB

PEE2: COSTS AND CONSEQUENCES OF OLOPATAD

PEE2: COSTS AND CONSEQUENCES OF OLOPATADINE 0.1% VERSUS LEVOCABASTINE 0.05% IN THE TREATMENT OF SEASONAL ALLERGIC CONJUNCTIVITIS

✍ A Lafuma; F Fagnani; M Nuijten; G Berdeaux 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Randomized, double-masked, placebo-contr

Randomized, double-masked, placebo-controlled comparison of the efficacy of emedastine difumarate 0.05% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the human conjunctival allergen challenge model

✍ Peter A. D'Arienzo; Andrea Leonardi; George Bensch 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 489 KB

Efficacy and safety of ketorolac trometh

Efficacy and safety of ketorolac tromethamine 0.5% and levocabastine 0.05%: a multicenter comparison in patients with seasonal allergic conjunctivitis

✍ Peter C. Donshik; David Pearlman; Jacob Pinnas; Michael B. Raizman; Joseph Taube 📂 Article 📅 2000 🏛 Springer Healthcare Communications 🌐 English ⚖ 144 KB

Evaluation of the onset and duration of

Evaluation of the onset and duration of effect of Azelastine Eye Drops (0.05%) versus placebo in patients with allergic conjunctivitis using an allergen challenge model

✍ Mitchell H Friedlaender; Judith Harris; Nicole LaVallee; Heidy Russell; Jonathan 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 252 KB